Jinling Pharmaceutical Co., Ltd.

Jinling Pharmaceutical Co., Ltd. Progress Announcement on Cash Management of Idle Raised Funds

Announcement on Court Appointment of Bankruptcy Administrator for Nanjing Jingu Hospital Management Co., Ltd.

Jinling Pharmaceutical Co., Ltd. 2025 Sustainable Development Report

Announcement on Approval of Chemical Raw Material Drug Listing Application by Controlling Subsidiary of Jinling Pharmaceutical Co., Ltd.

Announcement of Resolutions from the 25th Meeting of the 9th Board of Directors of Jinling Pharmaceutical Co., Ltd.

Q1 2026 Report

Legal Opinion on the 2025 Annual Shareholders' Meeting of Jinling Pharmaceutical Co., Ltd. by Jiangsu Taihe Law Firm

Jinling Pharmaceutical Co., Ltd. 2025 Annual Shareholders Meeting Resolution Announcement

Jinling Pharmaceutical Co., Ltd. Announcement on Subsidiary's Bankruptcy Review Notification

Jinling Pharmaceutical Co., Ltd. Announcement on Rejection of Drug Market Application by Subsidiary

CITIC Securities Co., Ltd. Report on Ongoing Supervision of Jinling Pharmaceutical Co., Ltd. for 2025

CITIC Securities Co., Ltd. Report on Sponsorship Work for Jinling Pharmaceutical Co., Ltd. for 2025

CITIC Securities Co., Ltd. Summary Report on Continuous Supervision of JINLING Pharmaceutical Co., Ltd.'s 2023 Private Placement

Announcement on Abnormal Stock Trading Fluctuations of Jinling Pharmaceutical Co., Ltd.

Announcement on Submission of Investment Intent Letter by JINLING Pharmaceutical Co., Ltd.

Report on Continuous Supervision Training for JINLING Pharmaceutical Co., Ltd. by CITIC Securities Co., Ltd. for 2025

Announcement of Online Performance Briefing for 2025 by Jinling Pharmaceutical Co., Ltd.

CITIC Securities Co., Ltd. Review Opinion on Jinling Pharmaceutical Co., Ltd.'s 2025 Fundraising Storage and Usage

Special Explanation on Asset Impairment Provisioning

CITIC Securities Co., Ltd. Review Opinion on JINLING Pharmaceutical Co., Ltd. 2025 Internal Control Self-Assessment Report

Announcement on Appointment of Accounting Firm for 2026 by JINLING Pharmaceutical Co., Ltd.

Review Opinions from the Second Special Meeting of Independent Directors in 2026

2025 Annual Board of Directors Work Report

Independent Director's 2025 Annual Performance Report (Gao Yanping)

Independent Director's 2025 Annual Performance Report (Shen Yongjian)

Independent Director's 2025 Annual Report (Kou Junping)

2025 Internal Control Audit Report

2025 Internal Control Self-Assessment Report

Announcement on the Dissolution and Liquidation of a Subsidiary by JINLING Pharmaceutical Co., Ltd.

Announcement on Asset Impairment Provision for 2025 by JINLING Pharmaceutical Co., Ltd.

Special Report on the Use and Storage of Raised Funds for 2025 by JINLING Pharmaceutical Co., Ltd.

Announcement on the Execution of Routine Related Transactions for 2025 by JINLING Pharmaceutical Co., Ltd.

Notice of 2025 Annual Shareholders Meeting of Jinling Pharmaceutical Co., Ltd.

Announcement of Resolutions from the 24th Meeting of the 9th Board of Directors of Jinling Pharmaceutical Co., Ltd.

Jinling Pharmaceutical Co., Ltd. 2025 Profit Distribution Plan

Verification Report on the Special Report of Fundraising Management and Usage for JINLING Pharmaceutical Co., Ltd. in 2025

Evaluation Report on the Performance of Accounting Firms for 2025

Report on the Audit Committee's Oversight of the Accounting Firm's Responsibilities for 2025

Special Report on Non-Operational Fund Occupation and Other Related Fund Transactions of Jinling Pharmaceutical Co., Ltd.

Summary of Non-Operating Fund Occupation and Other Related Fund Transactions for 2025

Special Opinion on the Independence of Independent Directors for the 2025 Fiscal Year

2025 Annual Audit Report

2025 Annual Report

Summary of the 2025 Annual Report

Announcement on the Use of Idle Funds for Entrusted Wealth Management by JINLING Pharmaceutical Co., Ltd. and Its Subsidiaries

Announcement on Completion of Liquidation and Deregistration of Wholly-Owned Subsidiary by Jinling Pharmaceutical Co., Ltd.